Safety of Non-MS Biologics in Patients with Multiple Sclerosis: A Multi-center Retrospective Study of MS Patients with Co-morbid Autoimmune Conditions (S40.007)

Evan Madill; Kerry Lenzi; Kristin Galetta; John Lincoln; Erin Longbrake; Gloria von Geldern; Jacob Sloane; Hamza Coban; Asya Wallach; Josef Gutman; Nancy Le; Carolyn Akers; Raveena Vij; Tamar Bacon; Laura Naydovich; Caitlin Pileggi; Jeffrey Xi; Bruna de Freitas Dias; J A Hobbs; Alexandra Balshi; Mary Picone; Josephine Vonderhaar; Daniel Kantor; Shamik Bhattacharyya; Ilya Kister

doi:10.1212/wnl.0000000000217367

Key Points

This research aims to evaluate the safety profile of non-MS biologics in multiple sclerosis patients who also have autoimmune diseases.
Retrospective study design
Multi-center data collection
Focus on patients with multiple sclerosis and co-morbid autoimmune conditions.
Safety data indicates potential risks associated with non-MS biologics in this population.
Specific adverse events related to treatment were documented, requiring further scrutiny.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Retrospective study assesses the safety of non-MS biologics in patients with multiple sclerosis with co-morbid autoimmune diseases, indicating important safety considerations.

Abstract

To assess the safety of non-MS biologics in patients with multiple sclerosis (MS) and co-morbid systemic autoimmune disease (AID).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Madill et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf3d6faef96ed7f05640c https://doi.org/10.1212/wnl.0000000000217367

View at Publisher

Ask AI

Bookmark

Share

Safety of Non-MS Biologics in Patients with Multiple Sclerosis: A Multi-center Retrospective Study of MS Patients with Co-morbid Autoimmune Conditions (S40.007)

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Safety of Non-MS Biologics in Patients with Multiple Sclerosis: A Multi-center Retrospective Study of MS Patients with Co-morbid Autoimmune Conditions (S40.007)

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading